Loading...

Affinity Energy and Health

DB:GZA
Snowflake Description

Worrying balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
GZA
DB
A$9M
Market Cap
  1. Home
  2. DE
  3. Pharmaceuticals & Biotech
Company description

Affinity Energy and Health Limited operates as a plant-based health and wellbeing company in Australia, India, and the United States. The last earnings update was 55 days ago. More info.


Add to Portfolio Compare Print
  • Affinity Energy and Health has significant price volatility in the past 3 months.
GZA Share Price and Events
7 Day Returns
0%
DB:GZA
-0.1%
DE Biotechs
1%
DE Market
1 Year Returns
-66.7%
DB:GZA
-7.4%
DE Biotechs
-5.6%
DE Market
GZA Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Affinity Energy and Health (GZA) 0% 0% -16.7% -66.7% -73.1% -89.7%
DE Biotechs -0.1% 6% -6.7% -7.4% 53.2% 11.6%
DE Market 1% 6.1% 8.4% -5.6% 10.9% 13.8%
1 Year Return vs Industry and Market
  • GZA underperformed the Biotechs industry which returned -7.4% over the past year.
  • GZA underperformed the Market in Germany which returned -5.6% over the past year.
Price Volatility
GZA
Industry
5yr Volatility vs Market

Value

 Is Affinity Energy and Health undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Affinity Energy and Health. This is due to cash flow or dividend data being unavailable. The share price is €0.005.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Affinity Energy and Health's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Affinity Energy and Health's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:GZA PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in AUD A$-0.01
ASX:AEB Share Price ** ASX (2019-01-31) in AUD A$0.01
Europe Biotechs Industry PE Ratio Median Figure of 30 Publicly-Listed Biotechs Companies 22.73x
Germany Market PE Ratio Median Figure of 424 Publicly-Listed Companies 19.72x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Affinity Energy and Health.

DB:GZA PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:AEB Share Price ÷ EPS (both in AUD)

= 0.01 ÷ -0.01

-0.9x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Affinity Energy and Health is loss making, we can't compare its value to the Europe Biotechs industry average.
  • Affinity Energy and Health is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Affinity Energy and Health's expected growth come at a high price?
Raw Data
DB:GZA PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.9x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Europe Biotechs Industry PEG Ratio Median Figure of 22 Publicly-Listed Biotechs Companies 1.3x
Germany Market PEG Ratio Median Figure of 269 Publicly-Listed Companies 1.58x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Affinity Energy and Health, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Affinity Energy and Health's assets?
Raw Data
DB:GZA PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in AUD A$0.00
ASX:AEB Share Price * ASX (2019-01-31) in AUD A$0.01
Germany Biotechs Industry PB Ratio Median Figure of 15 Publicly-Listed Biotechs Companies 3.72x
Germany Market PB Ratio Median Figure of 574 Publicly-Listed Companies 1.87x
DB:GZA PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:AEB Share Price ÷ Book Value per Share (both in AUD)

= 0.01 ÷ 0.00

10.18x

* Primary Listing of Affinity Energy and Health.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Affinity Energy and Health is overvalued based on assets compared to the DE Biotechs industry average.
X
Value checks
We assess Affinity Energy and Health's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Biotechs industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Biotechs industry average (and greater than 0)? (1 check)
  5. Affinity Energy and Health has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Affinity Energy and Health expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Affinity Energy and Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
47.6%
Expected Biotechs industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Affinity Energy and Health expected to grow at an attractive rate?
  • Unable to compare Affinity Energy and Health's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Affinity Energy and Health's earnings growth to the Germany market average as no estimate data is available.
  • Unable to compare Affinity Energy and Health's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
DB:GZA Future Growth Rates Data Sources
Data Point Source Value (per year)
Germany Biotechs Industry Earnings Growth Rate Market Cap Weighted Average 47.6%
Germany Biotechs Industry Revenue Growth Rate Market Cap Weighted Average 26.1%
Germany Market Earnings Growth Rate Market Cap Weighted Average 11.6%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:GZA Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in AUD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:GZA Past Financials Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income *
2018-12-31 -5 -9
2018-09-30 -5 -8
2018-06-30 -5 -8
2018-03-31 -4 -7
2017-12-31 -3 -5
2017-09-30 -3 -4
2017-06-30 -3 -4
2017-03-31 -3 -4
2016-12-31 -3 -4
2016-09-30 -3 -3
2016-06-30 -3 -3
2016-03-31 -3 -3

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Affinity Energy and Health is high growth as no earnings estimate data is available.
  • Unable to determine if Affinity Energy and Health is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:GZA Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Affinity Energy and Health Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:GZA Past Financials Data
Date (Data in AUD Millions) EPS *
2018-12-31 -0.01
2018-09-30 -0.01
2018-06-30 -0.01
2018-03-31 -0.01
2017-12-31 -0.01
2017-09-30 -0.01
2017-06-30 -0.01
2017-03-31 -0.01
2016-12-31 -0.01
2016-09-30 -0.01
2016-06-30 -0.01
2016-03-31 -0.01

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Affinity Energy and Health will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of GZA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. Affinity Energy and Health's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Pharmaceuticals & Biotech companies here
  3. Affinity Energy and Health's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Affinity Energy and Health's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Affinity Energy and Health has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Affinity Energy and Health performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Affinity Energy and Health's growth in the last year to its industry (Biotechs).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Affinity Energy and Health does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Affinity Energy and Health's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Affinity Energy and Health's 1-year growth to the Europe Biotechs industry average as it is not currently profitable.
Earnings and Revenue History
Affinity Energy and Health's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Affinity Energy and Health Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:GZA Past Revenue, Cash Flow and Net Income Data
Date (Data in AUD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 -8.83 7.97
2018-09-30 -8.46 7.72
2018-06-30 -8.10 7.46
2018-03-31 -6.54 6.51
2017-12-31 -4.99 5.56
2017-09-30 -4.39 5.22
2017-06-30 -3.79 4.88
2017-03-31 -3.70 5.12
2016-12-31 -3.61 5.36
2016-09-30 -3.43 5.25
2016-06-30 -3.26 5.14
2016-03-31 -3.46 4.94 -0.01
2015-12-31 -3.66 4.74 -0.02
2015-09-30 -3.19 4.54 -0.01
2015-06-30 -2.72 4.34
2015-03-31 -2.24 4.51 0.01
2014-12-31 -1.75 4.68 0.01
2014-09-30 -1.97 4.81 0.03
2014-06-30 -2.18 4.94 0.05
2014-03-31 -2.38 4.72 0.20
2013-12-31 -2.59 4.50 0.35
2013-09-30 -3.50 5.17 0.54
2013-06-30 -4.42 5.84 0.74
2013-03-31 -5.54 5.99 1.20
2012-12-31 -6.67 6.13 1.66
2012-09-30 -6.20 5.53 1.44
2012-06-30 -5.74 4.94 1.23

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Affinity Energy and Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Affinity Energy and Health has efficiently used its assets last year compared to the Europe Biotechs industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Affinity Energy and Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Affinity Energy and Health's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Biotechs industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Affinity Energy and Health has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Affinity Energy and Health's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Affinity Energy and Health's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Affinity Energy and Health's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Affinity Energy and Health has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Affinity Energy and Health's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Affinity Energy and Health Company Filings, last reported 3 months ago.

DB:GZA Past Debt and Equity Data
Date (Data in AUD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 0.86 4.02 0.01
2018-09-30 0.86 4.02 0.01
2018-06-30 4.41 4.24 0.89
2018-03-31 4.41 4.24 0.89
2017-12-31 2.19 2.15 0.58
2017-09-30 2.19 2.15 0.58
2017-06-30 -3.53 6.18 0.10
2017-03-31 -3.53 6.18 0.10
2016-12-31 -2.36 4.14 0.18
2016-09-30 -2.36 4.14 0.18
2016-06-30 -0.65 3.94 0.27
2016-03-31 -0.65 3.94 0.27
2015-12-31 0.51 1.44 0.13
2015-09-30 0.51 1.44 0.13
2015-06-30 2.02 2.29 1.11
2015-03-31 2.02 2.29 1.11
2014-12-31 2.65 0.96 1.47
2014-09-30 2.65 0.96 1.47
2014-06-30 1.74 2.20 0.30
2014-03-31 1.74 2.20 0.30
2013-12-31 0.61 1.44 0.16
2013-09-30 0.61 1.44 0.16
2013-06-30 0.50 3.51 0.23
2013-03-31 0.50 3.51 0.23
2012-12-31 1.30 1.47 0.49
2012-09-30 1.30 1.47 0.49
2012-06-30 3.52 0.63 1.59
  • Affinity Energy and Health's level of debt (466.5%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (233.8% vs 466.5% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Affinity Energy and Health has less than a year of cash runway based on current free cash flow.
  • Affinity Energy and Health has less than a year of cash runway if free cash flow continues to grow at historical rates of 21.8% each year.
X
Financial health checks
We assess Affinity Energy and Health's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Affinity Energy and Health has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Affinity Energy and Health's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Affinity Energy and Health dividends.
If you bought €2,000 of Affinity Energy and Health shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Affinity Energy and Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Affinity Energy and Health's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:GZA Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Europe Biotechs Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 0.9%
Germany Market Average Dividend Yield Market Cap Weighted Average of 327 Stocks 3%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.4%
Germany Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Affinity Energy and Health has not reported any payouts.
  • Unable to verify if Affinity Energy and Health's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Affinity Energy and Health's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Affinity Energy and Health has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Affinity Energy and Health's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Affinity Energy and Health afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Affinity Energy and Health has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Affinity Energy and Health's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Mal Scott James
COMPENSATION A$637,355
AGE 62
TENURE AS CEO 1.4 years
CEO Bio

Mr. Malcolm Raymond Scott James, also known as Mal, BBusS, CPA, FAICD, MAusIMM, serves as the Principal of MRJ Advisors. Mr. James serves as a Non Executive Finance Director of Eureka Mining PLC, Caspian Holdings plc and Cordillera Resources plc. He is a Partner in a boutique resource development and financing consultancy. He has been Executive Director of Tianshan Goldfields Ltd. since 2002. He served as Finance Director at Peninsula Energy Limited and served as its Executive Director of Finance & Operations since January 1, 2011. He is a highly experienced company director with an extensive background in finance, accounting and resources. This includes a focus in uranium, developed over ten years at Peninsula Energy where he served as Executive Director responsible for the daily operations through to finance. Mr. James served as the Chief Executive Officer of the Australian Employment Covenant, sustainable jobs for indigenous Australians and Chief Executive Officer of the Australian Children’s Trust. Mr. James has played an active role in the identification, acquisition, exploration, financing and development of several mining projects around the world. He worked on projects in Australia, Southern Africa, Asia Pacific Rim, Middle East and the FSU. He served as an Executive Director of Peninsula Energy Limited until February 27, 2013. He has over 27 years experience in finance, project development and public company management. He has been the Non Executive Chairman and Director at Affinity Energy and Health Ltd since September 16, 2014 and Alecto Energy plc since August 2009. He has been Non-Executive Chairman of Moko Social Media Limited since October 07, 2016. He serves as the Non Executive Chairman of Anova Metals Limited and Anova Minerals Ltd. He served as the Non-Executive Chairman of Alecto Minerals plc from August 2009 to April 4, 2013. He served as Non-Executive Chairman and Non-Executive Director of Triton Minerals Limited (Triton Gold Limited) from October 31, 2011 to January 28, 2014. Mr. James served as the Chairman of Lefroy Resources Ltd., until April 17, 2009. He served as the Non-Executive Chairman of Peninsula Energy Limited from April 11, 2005 to October 2007. He served as the Non-Executive Chairman of Torrens Energy Limited until July 10, 2007. He has been a Non-Executive Director of Vimy Resources Limited since April 01, 2016. He has been a Non Executive Director of Anova Metals Limited since September 10, 2012 and Alecto Energy plc since April 2006. He has been a Director of Uranium King Pty Ltd. since July 2, 2008. He serves as a Director at Basketball Australia, Eureka Mining Plc., Cordillera Resources Plc and Kanowna Lights Limited (all ASX listed). He has been the Non-Executive Director of Moko Social Media Limited since October 07, 2016. He served as Non Executive Director of Alecto Minerals plc from April 2006 to April 2013. He served as a Director of Lefroy Resources Ltd., until April 17, 2009. He served as a Non-executive Director at W Resources Plc until May 2006 and AusAmerican Mining Limited (formerly Australian American Mining Corporation Limited, Monaro Mining NL) from October 5, 2007 to December 17, 2008. Mr. James served as a Founding Director of Resource & Capital Management, a boutique resource and capital management firm that was responsible for the identification, financing and listing of several projects / companies on the Australian and London Stock Exchanges. He served as a Non Executive Finance Director of Empyrean Energy plc until July 3, 2007. He served as a Non-Executive Director of Peninsula Energy Limited since December 8, 2003. He served as a Director of Caspian Holdings Plc until May 18, 2006. He served as Director of Atlantic Carbon Group plc until November 2007. He served as a Director of Atlantic Coal plc until November 2007. He served as a Director of Empyrean Energy Plc until July 3, 2007. He served as a Non-Executive Director of Summit Resources Plc. Mr. James served as Non-Executive Director of Anaconda Nickel Limited and International Goldfields Limited from 2002 to April 7, 2006. Mr. James serves as Executive Chairman and Managing Director since November 28, 2017 at Affinity Energy and Health Ltd. He served as Non-Executive Director of Woomera Mining Limited (formerly, Ausroc Metals Limited) from October 05, 2007 to December 17, 2008. He served as Non Executive Director of Siberia Mining Corporation Limited from March 6, 2003 to December 17, 2004. He served as Non-Executive Director of Moly Mines Ltd., until December 2004. Mr. James is also a Fellow of the Australian Institute of Company Directors and an Associate of the Australasian Institute of Mines and Metallurgy. He is a Certified Public Accountant. Mr. James holds Bbus, FAID and MAusIMM and Bachelor of Business (Accounting) from RMIT University, in Melbourne, Australia.

CEO Compensation
  • Mal's compensation has increased whilst company is loss making.
  • Mal's remuneration is higher than average for companies of similar size in Germany.
Management Team

Mal Scott James

TITLE
Executive Chairman & MD
COMPENSATION
A$637K
AGE
62
TENURE
1.4 yrs

Garnet McConchie

TITLE
Executive Director
COMPENSATION
A$520K
AGE
67

James Vosper

TITLE
Medical Marijuana Consultant
TENURE
1.7 yrs
Board of Directors Tenure

Average tenure of the Affinity Energy and Health board of directors in years:

4.6
Average Tenure
  • The tenure for the Affinity Energy and Health board of directors is about average.
Board of Directors

Mal Scott James

TITLE
Executive Chairman & MD
COMPENSATION
A$637K
AGE
62
TENURE
4.6 yrs

Garnet McConchie

TITLE
Executive Director
COMPENSATION
A$520K
AGE
67
TENURE
10.7 yrs

Josh Puckridge

TITLE
Non-Executive Director

Jith Veeravalli

TITLE
Alternate Non-Executive Director
TENURE
1.7 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Affinity Energy and Health's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Affinity Energy and Health has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Affinity Energy and Health Limited operates as a plant-based health and wellbeing company in Australia, India, and the United States. It engages in developing technology to produce commercial quantities of algae and medicinal cannabis for supply to algae-based nutraceuticals, animal feed and aquaculture, medicinal cannabis, and biofuels markets. The company offers FeedMe Algae, an algae-based aqua feed; and algae-based biofuels. Affinity Energy and Health Limited was founded in 2007 and is based in Subiaco, Australia.

Details
Name: Affinity Energy and Health Limited
GZA
Exchange: DB
Founded: 2007
A$5,505,908
974,925,475
Website: http://www.affinityenergyandhealth.com.au
Address: Affinity Energy and Health Limited
Spectrum Offices,
Unit 2,
Subiaco,
Western Australia, 6008,
Australia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX AEB Ordinary Shares Australian Securities Exchange AU AUD 13. Jan 2011
DB GZA Ordinary Shares Deutsche Boerse AG DE EUR 13. Jan 2011
CHIA AEB Ordinary Shares Chi-X Australia AU AUD 13. Jan 2011
OTCPK ALGX.Y SPONSORED ADR Pink Sheets LLC US USD 21. Apr 2011
Number of employees
Current staff
Staff numbers
0
Affinity Energy and Health employees.
Industry
Biotechnology
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/24 22:01
End of day share price update: 2019/01/31 00:00
Last earnings filing: 2019/02/28
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.